Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
1.570
-0.010 (-0.63%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Aldeyra Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 94 | 312 | 297 | 206 | 408 | 232 | |
| Market Cap Growth | -17.12% | 4.88% | 43.92% | -49.34% | 75.40% | -12.74% | |
| Enterprise Value | 40 | 252 | 240 | 79 | 260 | 132 | |
| Last Close Price | 1.57 | 5.18 | 4.99 | 3.51 | 6.96 | 4.00 | |
| PB Ratio | 2.13 | 7.04 | 4.18 | 1.72 | 2.70 | 1.13 | |
| P/TBV Ratio | 2.14 | 7.04 | 4.18 | 1.72 | 2.70 | 1.13 | |
| Debt / Equity Ratio | 0.35 | 0.35 | 0.22 | 0.13 | 0.11 | 0.08 | |
| Net Debt / Equity Ratio | -1.23 | -1.23 | -1.21 | -1.06 | -1.05 | -0.43 | |
| Net Debt / EBITDA Ratio | 1.56 | 1.56 | 1.43 | 2.99 | 2.54 | 1.59 | |
| Net Debt / FCF Ratio | 1.64 | 1.64 | 1.99 | 4.19 | 2.79 | 2.09 | |
| Quick Ratio | 2.52 | 2.52 | 5.44 | 6.42 | 11.56 | 8.90 | |
| Current Ratio | 2.58 | 2.58 | 5.60 | 6.64 | 11.79 | 19.77 | |
| Return on Equity (ROE) | -58.73% | -58.73% | -58.54% | -27.73% | -34.77% | -43.56% | |
| Return on Assets (ROA) | -24.95% | -24.95% | -29.71% | -16.23% | -18.91% | -22.20% | |
| Return on Capital Employed (ROCE) | -79.70% | -79.70% | -69.90% | -33.90% | -37.80% | -25.40% | |
| Earnings Yield | -35.82% | -10.86% | -18.80% | -18.18% | -15.22% | -24.86% | |
| FCF Yield | -35.29% | -10.70% | -14.54% | -14.69% | -13.90% | -18.32% | |
| Buyback Yield / Dilution | -0.96% | -0.96% | -0.92% | -0.92% | -8.08% | -59.11% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.